HeartSciences (HSCS) Gross Margin (2021 - 2025)

HeartSciences has reported Gross Margin for 5 years, with the latest figure at 58.33% in Q4 2025.

• For the quarter ending Q4 2025, Gross Margin changed N/A year-over-year to 58.33%; the trailing twelve-month figure through Jan 2026 stood at 57.92% (down 939.0% YoY), and the FY2025 full-year result was 56.78%, down 1052.0% from the prior year.
• Gross Margin for Q4 2025 stood at 58.33%, down from 60.0% in the prior quarter.
• The five-year high for Gross Margin was 69.15% in Q2 2022, with the low at 23.09% in Q3 2021.
• Historically, Gross Margin has averaged 56.36% across 5 years, with a median of 60.51% in 2025.
• Annual changes were most pronounced in 2022 — Gross Margin soared 1329 bps — and 2023, when it tumbled 781 bps.
• HeartSciences' Gross Margin stood at 23.09% in 2021, then jumped by 58 bps to 36.38% in 2022, then soared by 68 bps to 61.03% in 2023, then advanced by 13 bps to 68.97% in 2024, then slipped by 15 bps to 58.33% in 2025.
• The last three Gross Margin figures came in at 58.33% (Q4 2025), 60.0% (Q3 2025), and 56.78% (Q2 2025), per Business Quant data.